Peptides

  • Mod GRF 1-29 & Ipamorelin Blend (10mg)

    Size: 10mg Contents: Mod GRF 1-29 (5mg) & Ipamorelin (5mg) Form: Lyophilized powder Purity: >99% Mod GRF 1-29 & Ipamorelin (10mg) is a synergistic blend of two peptides designed to enhance growth hormone release. Mod GRF 1-29, an analog of growth hormone-releasing hormone (GHRH), promotes increased GH secretion, while Ipamorelin acts as a selective ghrelin receptor agonist, further stimulating growth hormone release. Together, they support muscle growth, fat loss, and improved recovery, making this combination popular among athletes and fitness enthusiasts looking to optimize performance and body composition. $184.00
  • Tirzepatide 30mg

    Tirzepatide 30 mg is a ≥ 99 % pure dual-receptor peptide supplied as a lyophilized powder for in-vitro GLP-1 / GIP research. For laboratory use only—no human or veterinary applications. Tirzepatide is a synthetic peptide under investigation for concurrent agonist activity at GLP-1 and GIP receptors. Ongoing in-vitro studies explore dual-receptor signalling pathways relevant to metabolic research models.

    Specification

    • Peptide Name: Tirzepatide
    • Content: 30 mg lyophilized powder (requires reconstitution)
    • Purity: ≥ 99 % (HPLC / MS certificate available)
    • Manufacturing: ISO 9001:2015 & cGMP-audited facility
    • Intended Use: In-vitro laboratory research only

    Storage & Handling

    • Prior to reconstitution: store ≤ 8 °C in a dry environment
    • After reconstitution: refrigerate 2 – 8 °C and use within 30 days
    • For extended preservation: aliquot and freeze at −20 °C
    • Avoid repeated freeze–thaw cycles

    Compliance Notice

    Supplied exclusively to qualified professionals for controlled laboratory applications. No dosage or administration guidance is provided. Buyer assumes responsibility for safe handling and regulatory adherence. $195.00
  • Tirzepatide 60mg

    Tirzepatide is a synthetic peptide under investigation for concurrent agonist activity at GLP-1 and GIP receptors. Ongoing in-vitro studies explore dual-receptor signaling pathways relevant to metabolic research models.

    Specification

    • Peptide Name: Tirzepatide
    • Content: 60 mg lyophilized powder (requires reconstitution)
    • Purity: ≥ 99 % (HPLC / MS certificate available)
    • Manufacturing: ISO 9001:2015 & cGMP-audited facility
    • Intended Use: In-vitro laboratory research only

    Storage & Handling

    • Prior to reconstitution: store ≤ 8 °C in a dry environment
    • After reconstitution: refrigerate 2 – 8 °C and use within 30 days
    • For extended preservation: aliquot and freeze at −20 °C
    • Avoid repeated freeze–thaw cycles

    Compliance Notice

    Supplied exclusively to qualified professionals for controlled laboratory applications. No dosage or administration guidance is provided. Buyer assumes responsibility for safe handling and regulatory adherence. $300.00